<p class="MsoNormal" style= "mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-add-space: auto;"> Listen to Rodica Busui (Pop-Busui), MD, PhD, Neha J. Pagidipati, MD, MPH, and Jennifer B. Green, MD discuss ASCVD (atherosclerotic cardiovascular disease) progression in patients with type 2 diabetes, strategies to assess its risk, and the COORDINATE study.</p>

Listen to Rodica Busui (Pop-Busui), MD, PhD, Neha J. Pagidipati, MD, MPH, and Jennifer B. Green, MD discuss ASCVD (atherosclerotic cardiovascular disease) progression in patients with type 2 diabetes, strategies to assess its risk, and the COORDINATE study.

<p> Listen to Rodica Busui (Pop-Busui), MD, PhD, Neha J. Pagidipati, MD, MPH, and Jennifer B. Green, MD discuss ASCVD (atherosclerotic cardiovascular disease) progression in patients with type 2 diabetes, strategies to assess its risk, and the COORDINATE study.</p>

Understanding ASCVD Progression in Patients with Type 2 Diabetes, and Strategies to Assess its Risk

The American Heart Association Professional Education Podcast Series focuses on diabetes. Diabetes is one of the major controllable risk factors for cardiovascular disease (CVD). People living with type 2 diabetes are more likely to develop and die from cardiovascular diseases, such as heart attacks, strokes, and heart failure, as well as develop other risk factors such as chronic kidney disease than people who don't have diabetes. Explore this podcast series and raise your awareness and understanding of the link between diabetes and CVD.

Share Understanding ASCVD Progression in Patients with Type 2 Diabetes, and Strategies to Assess its Risk

Sign up to save your podcasts

Understanding ASCVD Progression in Patients with Type 2 Diabetes, and Strategies to Assess its Risk

Understanding ASCVD Progression in Patients with Type 2 Diabetes, and Strategies to Assess its Risk